Clinical Trials for Secondary Myelofibrosis

Find clinical trials for secondary myelofibrosis. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT ID: NCT06661915

This clinical trial is investigating a new treatment for advanced blood disorders known as myeloproliferative neoplasms (MPNs). Specifically, the study is comparing the effects of a medication call...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, New Lenox, Illinois, United States +3 more

Registry Platform Myelofibrosis and Anemia

NCT ID: NCT06976918

The "Registry Platform Myelofibrosis and Anemia" trial is a study aimed at gathering important information about patients who have myelofibrosis, a type of blood cancer, and anemia, a condition whe...

Not yet recruiting

Type: observational Locations: Multiple Locations, , Germany

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

NCT ID: NCT04370301

This clinical trial is investigating a new treatment approach for patients with primary or secondary myelofibrosis, a type of blood cancer. The study focuses on using a medication called a JAK inhi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

NCT ID: NCT04282187

This clinical trial is exploring the effectiveness of a combination treatment using decitabine and other medications—ruxolitinib, fedratinib, or pacritinib—for patients with advanced myeloprolifera...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

NCT ID: NCT04384692

This clinical trial is exploring how well a medication called ruxolitinib can help patients with primary or secondary myelofibrosis during the process of stem cell transplantation. Myelofibrosis is...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

NCT ID: NCT06516406

This clinical trial is studying the effects of a medication called ruxolitinib on patients with myelofibrosis, a type of blood cancer. The goal is to understand how different health factors might i...

Recruiting

Type: observational Locations: Milano, Lombardia, Italy, Monza, Lombardia, Italy +24 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions